NIH-funded research R21 grant

Using small molecules to help repair nerve injuries

Official title: Mid-sized GDNF Minics for Neural regeneration

Funded at Texas A&m University · NIH-11176596 · Data updated 2026-11-12

This study is working on new treatments that could help nerves heal better after injuries by creating small molecules that mimic a natural growth factor, which might lead to improved recovery for patients with nerve damage.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTexas A&m University
NIH-funded
Lab location1 site (College Station, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2025
Funding year2024
Award (this year)$72,100
NIH project number3R21NS130471-01A1S1
Project IDNIH-11176596 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced traumatic nerve injuries and are seeking innovative treatment options.

Less likely to help

Patients with non-traumatic nerve conditions or those who do not have nerve injuries may not benefit from this research.

What this research studies

This research focuses on developing small molecule mimics of glial cell line-derived neurotrophic factor (GDNF) to enhance nerve regeneration after traumatic injuries. By creating compounds that can effectively bind to specific receptors involved in neuronal signaling, the project aims to improve the stability and effectiveness of treatments for nerve damage. The approach involves designing and testing these mimics to facilitate communication between cells, potentially leading to better outcomes in nerve repair. Patients may benefit from advancements in therapies that promote healing and recovery of the peripheral nervous system.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for nerve injuries, improving recovery and quality of life for affected patients.

How similar studies have gone: While there have been some studies on GDNF and its family ligands, the specific approach of using small molecule mimics for nerve regeneration is relatively novel and has not been extensively tested.

Where this research is happening

  • Texas A&m University
    College Station, United States
    Active

Researchers

  • Principal investigator: Burgess, Kevin — Texas A&m University
  • Study coordinator: Burgess, Kevin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.